ASTCT Pharmacy SIG Online Journal Club - May 2021

The Pharmacy SIG Online Journal Club was presented live on May 19, 2021

Presenters & Articles

Jordyn Higgins, PharmD
PGY-2 Oncology Pharmacy Resident
Emory University Hospital Midtown/Winship Cancer Institute
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001):a multicentre seamless design study- Jordyn Higgins, PharmD (

Jordanne Adolphsen, PharmD
PGY-2 Oncology Pharmacy Resident
The University of Kansas Health System
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma ( )

Session Learning Objectives:
Upon completion of the activity, participants should be able to:

1. Discuss recent BMT pharmacy studies and their applications to current practice.
2. Evaluate the safety and efficacy of liso-cel for the treatment of large B-cell lymphomas (LBCL).
3. Assess the efficacy and safety of ide-cel in patients with triple exposed relapsed and refractory myeloma and to evaluate the pharmacokinetics, immunogenicity, and potential biomarkers for response and progression.

Information on CE, including disclosure information, can be found on the CE Information handout.


ASTCT Pharmacy SIG May 2021 Journal Club - Recording
Open to view video.
Open to view video.